Estradiol cypionate/testosterone enanthate (EC/TE), sold under the brand name Supligol, is an injectable combination medication of estradiol cypionate (EC), an estrogen, and testosterone enanthate (TE), an androgen/anabolic steroid, which is used in menopausal hormone therapy for women, to treat prostatic hypertrophy in men, to treat osteoporosis, and to suppress lactation in women, among other uses.[1][2] It contains 4 mg EC and 80 mg TE (57.5 mg free testosterone) in oil solution in each ampoule and is administered by intramuscular injection once every 3 to 6 weeks for hormone therapy in women.[1] The medication was marketed by 1976[1] and remains available today in Paraguay.[2]
 | |
 | |
| Combination of | |
|---|---|
| Estradiol cypionate | Estrogen |
| Testosterone enanthate | Androgen; Anabolic steroid |
| Clinical data | |
| Trade names | Supligol |
| Other names | EC/TE |
| Routes of administration | Intramuscular injection |
| Identifiers | |
| CAS Number | |
| Route | Medication | Major brand names | Form | Dosage |
|---|---|---|---|---|
| Oral | Testosterone undecanoate | Andriol, Jatenzo | Capsule | 40–80 mg 1x/1–2 days |
| Methyltestosterone | Metandren, Estratest | Tablet | 0.5–10 mg/day | |
| Fluoxymesterone | Halotestin | Tablet | 1–2.5 mg 1x/1–2 days | |
| Normethandronea | Ginecoside | Tablet | 5 mg/day | |
| Tibolone | Livial | Tablet | 1.25–2.5 mg/day | |
| Prasterone (DHEA)b | – | Tablet | 10–100 mg/day | |
| Sublingual | Methyltestosterone | Metandren | Tablet | 0.25 mg/day |
| Transdermal | Testosterone | Intrinsa | Patch | 150–300 μg/day |
| AndroGel | Gel, cream | 1–10 mg/day | ||
| Vaginal | Prasterone (DHEA) | Intrarosa | Insert | 6.5 mg/day |
| Injection | Testosterone propionatea | Testoviron | Oil solution | 25 mg 1x/1–2 weeks |
| Testosterone enanthate | Delatestryl, Primodian Depot | Oil solution | 25–100 mg 1x/4–6 weeks | |
| Testosterone cypionate | Depo-Testosterone, Depo-Testadiol | Oil solution | 25–100 mg 1x/4–6 weeks | |
| Testosterone isobutyratea | Femandren M, Folivirin | Aqueous suspension | 25–50 mg 1x/4–6 weeks | |
| Mixed testosterone esters | Climacterona | Oil solution | 150 mg 1x/4–8 weeks | |
| Omnadren, Sustanon | Oil solution | 50–100 mg 1x/4–6 weeks | ||
| Nandrolone decanoate | Deca-Durabolin | Oil solution | 25–50 mg 1x/6–12 weeks | |
| Prasterone enanthatea | Gynodian Depot | Oil solution | 200 mg 1x/4–6 weeks | |
| Implant | Testosterone | Testopel | Pellet | 50–100 mg 1x/3–6 months |
| Notes: Premenopausal women produce about 230 ± 70 μg testosterone per day (6.4 ± 2.0 mg testosterone per 4 weeks), with a range of 130 to 330 μg per day (3.6–9.2 mg per 4 weeks). Footnotes: a = Mostly discontinued or unavailable. b = Over-the-counter. Sources: See template. | ||||
See also
editReferences
edit- ^ a b c Vademecum de bolsillo: guía de especialidades medicinales : con índice terapéutico actualizado (enfermedades y síntomas de urgencia). Editorial Celcius - J.J. Vallory. 1976.
SUPLIGOL (Ampollas) Comp. Testosterona enantato 80 mg (-= Testosterona 57,5 mg) y Estradiol ciclopentil-propionato, 4 mg. — Indic. Climaterio y sus trastornos, hipertrofia de la próstata, osteoporosis, supresión de la lactancia, etc. — Doslf. Climaterio: 1 ampolla por via I.M. cada 3-6 semanas, segun el caso. Osteoporosis: 1 ampolla cada 3 semanas. Supresion de la lactancia: 1 ampolla despues del parto.
- ^ a b [1][dead link]
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |